Advanced Enzyme Technologies Balance Sheet Annual
BSE: - | NSE: - | ISIN: - | Sector: -| Fiscal Period | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Period End Date | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
| Total Liabilities Shareholders' Equity | 1,838.76 | 1,621.35 | 1,535.46 | 1,421.85 |
| Cash Equivalents | 115.93 | 66.75 | 71.75 | 36.84 |
| Other Liabilities Total | 5.39 | 1.37 | 0.89 | 0.51 |
| Long Term Debt | 7.89 | 9.03 | 6.65 | 7.28 |
| Common Stock Total | 22.38 | 22.38 | 22.37 | 22.37 |
| Other Current Assets Total | 12.65 | 1.60 | 1.95 | 0.69 |
| Total Assets | 1,838.76 | 1,621.35 | 1,535.46 | 1,421.85 |
| Current Portof LT Debt/ Capital Leases | 20.35 | 7.29 | 6.91 | 6.13 |
| Total Equity | 1,631.96 | 1,433.10 | 1,336.37 | 1,246.69 |
| Long Term Investments | 9.75 | 0.07 | 0.16 | 0.16 |
| Retained Earnings( Accumulated Deficit) | 1,609.57 | 1,162.58 | 1,087.07 | 1,006.83 |
| Total Common Shares Outstanding | 11.19 | 11.19 | 11.18 | 11.18 |
| Tangible Book Valueper Share Common Eq | 108.60 | 93.61 | 85.20 | 77.35 |
| Goodwill Net | 369.46 | 333.44 | 325.29 | 320.85 |
| Total Liabilities | 206.80 | 188.25 | 199.10 | 175.16 |
| Total Debt | 32.01 | 39.35 | 47.31 | 33.50 |
| Short Term Investments | 592.46 | 500.83 | 434.22 | 387.86 |
| Cashand Short Term Investments | 708.39 | 595.05 | 547.97 | 484.76 |
| Total Receivables Net | 145.26 | 120.49 | 103.42 | 106.22 |
| Deferred Income Tax | 31.87 | 33.63 | 34.32 | 37.23 |
| Accounts Receivable- Trade Net | 145.02 | 115.81 | 99.25 | 100.56 |
| Property/ Plant/ Equipment Total- Net | 327.00 | 314.63 | 307.27 | 288.82 |
| Minority Interest | 51.17 | 35.57 | 34.71 | 37.48 |
| Total Current Liabilities | 106.72 | 96.76 | 106.36 | 77.57 |
| Total Inventory | 177.28 | 159.10 | 152.44 | 128.13 |
| Accounts Payable | 39.96 | 17.20 | 15.76 | 24.22 |
| Other Currentliabilities Total | 46.41 | 30.38 | 38.92 | 31.38 |
| Total Long Term Debt | 11.66 | 20.92 | 22.82 | 22.38 |
| Intangibles Net | 46.92 | 52.31 | 58.29 | 60.88 |
| Other Long Term Assets Total | 18.93 | 21.54 | 19.89 | 16.84 |
| Note Receivable- Long Term | 23.13 | 19.49 | 14.82 | 12.18 |
| period Length | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 1,043.57 | 879.87 | 809.74 | 722.11 |
| Capital Lease Obligations | 3.77 | 11.89 | 16.16 | 15.10 |
| Accumulated Depreciation Total | - | -215.14 | -188.08 | -162.05 |
| Accrued Expenses | - | 30.74 | 27.18 | 10.85 |
| Other Equity Total | - | 164.12 | 144.80 | 135.37 |
| Prepaid Expenses | - | 3.62 | 3.96 | 2.32 |
| Additional Paid- In Capital | - | 84.02 | 82.13 | 82.13 |
| Cash | - | 27.48 | 42.00 | 60.05 |
| Property/ Plant/ Equipment Total- Gross | - | 506.34 | 463.05 | 433.76 |
| Notes Payable/ Short Term Debt | - | 11.15 | 17.58 | 4.99 |
Advanced Enzyme Technologies Quick Links
Advanced Enzyme Technologies Dividend Advanced Enzyme Technologies Bonus Advanced Enzyme Technologies News Advanced Enzyme Technologies AGM Advanced Enzyme Technologies Rights Advanced Enzyme Technologies Splits Advanced Enzyme Technologies Board Meetings Advanced Enzyme Technologies Key Metrics Advanced Enzyme Technologies Shareholdings Advanced Enzyme Technologies Profit Loss Advanced Enzyme Technologies Cashflow Advanced Enzyme Technologies Q1 Results Advanced Enzyme Technologies Q2 Results Advanced Enzyme Technologies Q3 Results Advanced Enzyme Technologies Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.